Asensus Surgical (NYSE:ASXC) announced today that it entered into a definitive agreement for the purchase and sale of $10 million in common stock. Research Triangle Park, North Carolina-based Asensus’ offering includes just over 23.8 million shares of common stock. It also includes warrants to purchase the same amount of shares in a registered direct offering. […]
Asensus Surgical
Leading U.S. hospital begins pediatric program with Asensus surgical robot platform
Asensus Surgical (NYSE:ASXC) announced today that an unnamed leading U.S. hospital initiated a pediatric program with its Senhance platform. Research Triangle Park, North Carolina-based Asensus picked up a pediatric indication for Senhance from the FDA in March. Senhance, Asensus’ flagship offering for its Performance-Guided Surgery, is a first-of-its-kind digital laparoscopic surgical robot. It uses augmented intelligence […]
What’s on the horizon in surgical robotics?
While question marks remain over where medtech is going, the path for surgical robotics remains full of excitement. Medical technology has experienced a bit of a rocky period lately. Layoffs continue to hamper the space, and financial outlooks are a bit cloudy for some companies. However, there remains plenty to look forward to in the […]
Asensus secures pediatric indication for its robotic surgery system
Asensus Surgical announced today that FDA has cleared an expanded pediatric indication for its Senhance robotic surgery system. Research Triangle Park, North Carolina–based Asensus says Senhance is the first and only digital laparoscopic surgery solution for pediatric patients. During the company’s fourth-quarter earnings announcement early this month, it said it expected the pediatric indication this […]
Asensus Surgical expects FDA clearance for surgical robot in pediatric use this year
Asensus Surgical (NYSE:ASXC) shares dipped today on fourth-quarter results that came in mixed compared to the consensus forecast. The company provided an outlook for the year ahead that includes the expected clearance of a regulatory hurdle, though. Shares of ASXC fell 2.6% to 67¢ apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which […]
Asensus Surgical unveils next-gen Luna surgical robot platform
Asensus Surgical (NYSE:ASXC) announced today that it introduced a next-generation surgical robot platform called “Luna.” Research Triangle Park, North Carolina-based Asensus designed luna as an integrated digital surgery solution. It features a next-generation surgical platform and instruments, plus real-time intraoperative clinical intelligence. Its final component, a secure cloud platform, applies machine learning to deliver clinical […]
Asensus, Karl Storz partner on surgical robot marketing, development
Asensus Surgical (NYSE:ASXC) announced today that it entered into a memorandum of understanding with Karl Storz VentureONE. Karl Storz VentureOne is a wholly-owned subsidiary of Karl Storz SE, a maker of endoscopes and other medical instruments and devices. The family-owned company closely collaborates with surgeons and healthcare partners around the globe on technologies for minimally invasive […]
Asensus Surgical to collaborate with Google Cloud on machine learning for surgical robots
Asensus Surgical (NYSE:ASXC) announced today that it entered into a multi-year collaboration with Google Cloud. The collaboration integrates Google Cloud’s secure cloud data architecture and machine learning into the Asensus surgical robot platform. It further expands the capabilities of Asensus’ performance-guided surgery framework through its Intelligent Surgical Unit (ISU). Research Triangle Park, North Carolina–based Asensus […]
Asensus Surgical wins CE mark approval for expanded machine learning
Asensus Surgical (NYSE:ASXC) announced today that it received CE mark for an expansion of machine vision capabilities with its surgical robot. The approval expands machine vision for the previously cleared Intelligent Surgical Unit (ISU) of the Senhance system. This regulatory nod makes the expanded ISU capabilities available across Europe, Japan and the U.S. The FDA […]
Asensus Surgical projects at least $2.2M in Q4 sales
Asensus Surgical (NYSE:ASXC) this week announced preliminary fourth-quarter results that came up well short of Wall Street estimates. The company expects to report revenues between $2.2 million and $2.8 million. Analysts expected the company to bring in approximately $3.7 million over the three months ended Dec. 31, 2022. Asensus expects its full-year revenue to total […]
Asensus Surgical announces another surgical robot placement in Japan
Asensus Surgical (NYSE:ASXC) announced today that it entered into a lease agreement with a Japanese hospital for its Senhance surgical robot. Research Triangle Park, North Carolina-based Asensus entered the agreement with Kitakyushu General Hospital. It marks the second Senhance system leased at the hospital in the Kyushu area of Japan. Asensus placed the first one […]